Soleno Therapeutics Ratios (2013-2026) | SLNO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)																	97.87%	98.27%	99.06%	98.73%
EBT Margin (Quarter)																	-14.42%	39.40%	47.27%	36.90%
EBIT Margin (Quarter)																	-19.98%	33.48%	43.15%	33.06%
EBITDA Margin (Quarter)																	-14.85%	39.82%	47.33%	30.79%
Operating Margin (Quarter)																	-19.98%	33.48%	43.15%	33.06%
Net Margin (Quarter)																	-14.42%	39.40%	47.27%	33.17%
FCF Margin (Quarter)																	-38.77%	65.88%	53.03%	27.42%
Efficiency
Inventory Average (Quarter)																		4.51M	10.85M	16.17M
Assets Average (Quarter)	52.74M	45.67M	39.06M	39.05M	39.70M	34.42M	29.24M	23.02M	25.24M	47.25M	122.12M	174.76M	236.48M	300.42M	313.84M	324.53M	325.20M	466.10M	581.86M	586.11M
Equity Average (Quarter)	32.50M	23.82M	19.00M	22.13M	23.38M	17.75M	12.77M	6.49M	7.53M	17.82M	90.36M	150.45M	212.07M	272.73M	254.91M	238.69M	236.20M	367.47M	472.46M	472.96M
Invested Capital (Quarter)	27.44M	20.20M	17.79M	26.46M	20.31M	15.20M	10.35M	2.64M	12.43M	23.22M	157.51M	143.39M	280.76M	264.70M	295.11M	232.26M	240.14M	494.81M	500.12M	495.80M
Asset Utilization Ratio (Quarter)																	0.11	0.21	0.33	0.49
Leverage & Solvency
Interest Coverage Ratio (Quarter)																-33.61	-4.74	15.90	29.34	24.21
Debt to Equity (Quarter)															0.20	0.21	0.21	0.10	0.11	0.10
Debt Ratio (Quarter)															0.15	0.16	0.15	0.08	0.09	0.08
Equity Ratio (Quarter)	0.56	0.47	0.50	0.62	0.55	0.48	0.39	0.14	0.40	0.37	0.87	0.85	0.92	0.89	0.74	0.73	0.72	0.82	0.80	0.81
Times Interest Earned (Quarter)																-33.61	-4.74	15.90	29.34	24.21
Valuation
Enterprise Value (Quarter)	-33.60M	-28.18M	-21.30M	-29.00M	-24.07M	-19.75M	-14.60M	-7.90M	-19.37M	-52.40M	-169.68M	-149.60M	-266.12M	-256.76M	-291.44M	-289.93M	-286.84M	-498.93M	-305.47M	-255.60M
Return Ratios
Return on Sales (Quarter)																	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-81.24%	-99.60%	-101.53%	-88.68%	-73.45%	-80.46%	-111.27%	-177.60%	-176.00%	-181.25%	-37.41%	-34.96%	-31.95%	-49.91%	-63.60%	-67.99%	-62.97%	-20.63%	1.81%	16.37%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.02%	-0.02%	-0.01%	-0.01%	-0.01%	-0.02%	-0.04%	-0.04%	-0.02%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%

Research Tools

Developers

Soleno Therapeutics Ratios (2013-2026) | SLNO

Research Tools

Developers

Soleno Therapeutics Ratios (2013-2026) | SLNO

Create an account

Sign In

Reset Password